main-logo

ICD-10 Code D05.12 | Intraductal carcinoma in situ of left breast Symptoms, Diagnosis, Billing

Intraductal carcinoma in situ of the left breast is a non-invasive breast cancer characterized by the proliferation of malignant cells within the ducts of the breast tissue. This condition is clinically significant as it can progress to invasive breast cancer if left untreated. Accurate coding with ICD-10 Code D05.12 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code D05.12 for Intraductal carcinoma in situ of left breast?

ICD-10 Code D05.12 specifically denotes intraductal carcinoma in situ of the left breast, indicating the presence of abnormal cells confined to the ducts without invasion into surrounding breast tissue. This code should be used in clinical documentation and billing when diagnosing patients with this condition, facilitating accurate treatment planning and reimbursement processes.

ICD-10 Code D05.12 – Clinical Definition and Explanation of Intraductal carcinoma in situ of left breast

Intraductal carcinoma in situ of the left breast arises from the epithelial cells lining the milk ducts and is considered a precursor to invasive breast cancer. It is crucial to identify and treat this condition promptly to prevent progression. Regular screening and awareness of risk factors are essential for early detection.

Key Clinical Features:

  • Presence of calcifications on mammography
  • Palpable mass may or may not be present
  • Typically asymptomatic in early stages
  • Higher risk of developing invasive breast cancer if untreated

ICD-10 Code D05.12 for Intraductal carcinoma in situ of left breast – SOAP Notes & Clinical Use

ICD-10 Code D05.12 is utilized in SOAP notes to document the diagnosis of intraductal carcinoma in situ of the left breast. It plays a critical role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.

What Does ICD-10 Code D05.12 for Intraductal carcinoma in situ of left breast Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D05.12 connects subjective reports from patients and objective clinical findings to a formal diagnosis of intraductal carcinoma in situ of the left breast. This code is vital for maintaining continuity of care, supporting accurate billing, and adhering to EHR documentation standards.

Treatment Options for ICD-10 Code D05.12 – Intraductal carcinoma in situ of left breast

Intraductal carcinoma in situ of the left breast requires timely intervention to prevent progression to invasive cancer. Treatment options may include surgical excision and, in some cases, radiation therapy.

Antibiotic Therapy:

    Supportive Care:

    • Regular follow-up appointments for monitoring
    • Patient education on breast health
    • Psychosocial support resources

    Infection Control:

      How to Document Symptoms of Intraductal carcinoma in situ of left breast (ICD-10 D05.12) in SOAP Notes

      Subjective:

      • Patient reports no palpable masses
      • Patient has a family history of breast cancer
      • Patient expresses anxiety about diagnosis
      • Patient reports recent mammogram showing calcifications

      Objective:

      • Mammogram reveals microcalcifications
      • Breast examination shows no palpable masses
      • No lymphadenopathy noted
      • Ultrasound confirms ductal abnormalities
      card-topcard-bottom

      Secure, compliant, and built for trust

      HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

      Learn more
      hipaa-icon

      SOAP Note Guidelines for Diagnosing Intraductal carcinoma in situ of left breast (ICD-10 Code D05.12)

      Assessment:

      • Diagnosis: Intraductal carcinoma in situ of left breast, non-invasive
      • ICD-10 Code: D05.12
      • Contributing factors: Family history of breast cancer
      • Patient education on condition and treatment options

      Plan:

      • Refer for surgical consultation for excision
      • Discuss potential need for radiation therapy
      • Schedule follow-up mammogram in 6 months
      • Provide resources for emotional support

      Treatment & Plan Section for ICD-10 Code D05.12 – Intraductal carcinoma in situ of left breast

      • Surgical excision is the primary treatment
      • Consideration of radiation therapy post-surgery
      • Patient education on self-breast examinations
      • Regular follow-up for monitoring and support

      Using ICD-10 Code D05.12 for Intraductal carcinoma in situ of left breast in Billing & SOAP Note Compliance

      • Ensure accurate documentation of symptoms and findings in SOAP notes
      • Use D05.12 in conjunction with relevant CPT codes for surgical procedures
      • Maintain compliance with coding guidelines to support billing
      • Document patient education and follow-up plans clearly

      ICD-10 Code D05.12 in Medical Billing and Insurance for Intraductal carcinoma in situ of left breast

      ICD-10 Code D05.12 is critical in medical billing, particularly in hospital and outpatient settings, ensuring accurate claims for treatment of intraductal carcinoma in situ of the left breast.

      Billing Notes:

      • Document all relevant clinical findings and patient history
      • Use D05.12 in conjunction with appropriate CPT codes for procedures
      • Ensure compliance with payer-specific guidelines for coding
      • Maintain detailed records to support claims

      Common CPT Pairings:

      CPT CodeDescription
      19301Mastectomy, partial (segmental resection)
      19281Biopsy of breast, needle
      77067Breast imaging, diagnostic mammography
      19302Mastectomy, total (simple)

      Frequently Asked Questions

      Common Questions About Using ICD-10 Code D05.12 for Intraductal carcinoma in situ of left breast

      What are the treatment options for intraductal carcinoma in situ?

      Treatment typically includes surgical excision, and in some cases, radiation therapy may be recommended to reduce the risk of recurrence. Regular follow-up is essential for monitoring.

      How is intraductal carcinoma in situ diagnosed?

      Diagnosis is usually made through mammography, which may reveal calcifications, followed by a biopsy to confirm the presence of abnormal cells.

      Is intraductal carcinoma in situ considered cancer?

      Yes, intraductal carcinoma in situ is classified as a non-invasive breast cancer, meaning it has not spread beyond the ducts into surrounding tissue.

      What is the prognosis for intraductal carcinoma in situ?

      The prognosis is generally favorable with appropriate treatment, as it is non-invasive. However, it requires monitoring due to the potential risk of progression to invasive cancer.

      diamond-bg
      diamond-bg

      Get started with your 20 free notes

      Sign up for free
      main-logo

      AI-aided Sudsy Shorthand for ink-free practices

      support@soapsuds.io
      hipaa-logo

      Clinical Notes

      SOAP notes

      DAP notes

      AI medical notes

      © Copyright SOAPsuds 2025. All rights reserved